Large liver cell dysplasia in hepatitis B virus X transgenic mouse liver and human chronic hepatitis B virus-infected liver

Intervirology

Volumn 48, Issue 1, 2005, Pages 16-22

  Koo, Ja Seung ^a   Seong, Je Kyung ^b,c   Park, Chanil ^a   Yu, Dae Yul ^d   Oh, Bong Kyeong ^a,b   Oh, Seung Hyun ^b,c   Park, Young Nyun ^a,b,e  

^a Yonsei University   (South Korea)

^b Yonsei University   (South Korea)

^c Seoul National University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Apoptosis; HBX transgenic mouse; Hepatitis B virus; Large liver cell dysplasia; Proliferation

Indexed keywords

BETA GALACTOSIDASE; CYCLINE; HEPATITIS B VIRUS X PROTEIN; VIRULENCE FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE LIVER CELL DYSPLASIA; LIVER CARCINOGENESIS; LIVER CIRRHOSIS; LIVER DISEASE; MOUSE; NICK END LABELING; NONHUMAN; PRECANCER; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS VIRULENCE;

ADULT; ANIMALS; APOPTOSIS; CELL AGING; DISEASE MODELS, ANIMAL; FEMALE; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; IN SITU NICK-END LABELING; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; TRANS-ACTIVATORS;

EID: 17244382225     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082090     Document Type: Article

References (30)

1. Beasley R: Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-1956.
2. Akagi G, Furuya K, Kanamura A, Chihara T, Otsuka H: Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma. Cancer 1984;54:315-318.
3. Ho JC, Wu PC, Mak TK: Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong. Int J Cancer 1981;28:571-574.
4. Omata M, Mori J, Yokosuka O, Iwama S, Ito Y, Okuda K: Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease-relationship with liver cell dysplasia. Liver 1982;2:125-132.
5. Sakurai M: Liver cell dysplasia and hepatitis B surface and core antigens in cirrhosis and hepatocellular carcinoma of autopsy cases. Acta Pathol Jpn 1978;28:705-719.
6. Anthony PP, Vogel CL, Barker LF: Liver cell dysplasia: A premalignant condition. J Clin Pathol 1973;26:217-223.
7. Anthony PP: Precursor lesion for liver cancer in humans. Cancer Res 1976;36:2579-2582.
8. Watanabe S, Okita K, Harada T, Kodama T, Numa Y, Takemoto T, Takahashi T: Morphologic studies of the liver cell dysplasia. Cancer 1983;51:2197-2205.
9. Adachi E, Hashimoto H, Tsuneyoshi M: Proliferating cell nuclear antigen in hepatocellular carcinoma and small liver cell dysplasia. Cancer 1993;72:2902-2909.
10. Roncalli M, Borzio M, Brando B, Colloredo G, Servida E: Abnormal DNA content in liver cell dysplasia: A flow cytometric study. Int J Cancer 1989;44:204-207.
11. Thomas RM, Berman JJ, Yetter RA. Moore W, Hutchins GM: Liver cell dysplasia: A DNA aneuploid lesion with distinct morphological features. Hum Pathol 1992;23:496-503.
12. Rubin EM, DeRose PB, Cohen C: Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma. Mod Pathol 1994;7:677-680.
13. Terris B, Ingster O, Rubbia L, Dubois S, Belghiti J, Feldmann G, Degott C, Henin D: Interphase cytogenetic analysis reveals numerical chromosome aberrations in large cell dysplasia. J Hepatol 1997;27:313-319.
14. Natarajan S, Theise ND, Thung SN, Antonio L, Paronetto F, Hytiroglou P: Large-cell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis. Am J Surg Pathol 1997;21:312-318.
15. Henmi A, Uchida T, Shikata T: Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma: Evidence against precancerous nature of liver cell dysplasia. Cancer 1985;55:2594-2599.
16. Lee RG, Tsamandas AC, Demetris AJ: Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: Matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology 1997;26:1415-1422.
17. Ganne-Carrie N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, Deny P, Trinchet JC, Callard P, Guettier C, Beaugrand M: Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 1996;23:1112-1118.
18. Le Bail B, Bernard PH, Carles J, Balabaud C, Bioulac-Sage P: Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants. J Hepatol 1997;27:835-842.
19. Libbrecht L, Craninx M, Nevens F, Desmet V, Roskams T: Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 2001;39:66-73.
20. Borzio M, Bruno S, Roncalli M, Mels GC, Ramella G, Borzio F, Leandro G, Servida E, Podda M: Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study. Gastroenterology 1995;108:812-817.
21. Kim CM, Koike K, Saito I, Miyamura T, Jay G: Hepatitis B virus HBx gene induces liver cancer in transgenic mice. Nature 1991;351:317-320.
22. Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H, Han YM, Lee CS, Park JS, Lee CH, Hyun BH, Murakami S, Lee KK: Incidence of hepatocellular carcinoma in the transgenic mice expressing hepatitis B virus X-protein. J Hepatol 1999;31:123-132.
23. Dimiri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-9367.
24. Paradis V, Youssef N, Dargere D, Ba N, Bonvoust F, Deschatrette J, Bedossa P: Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol 2001;32:327-332.
25. Grasl-Kraupp B, Ruttkay-Nedecky B, Mullauer L, Taper H, Huber W, Bursch W, Schulte-Hermann R: Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression. Hepatology 1997;25:906-912.
26. Hino N, Higashi T, Nouso K, Nakatsukasa H, Tsuji T: Apoptosis and proliferation of human hepatocellular carcinoma. Liver 1996;16:123-129.
27. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH, Harris CC: Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995;15:6012-6016.
28. Takada S, Kaneniwa N, Tsuchida N, Koike K: Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 1997;15:1895-1901.
29. Feitelson MA, Zhu M, Duan LX, London WT: Hepatitis X-antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993;8:1109-1117.
30. Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C, Levrero R: The hapatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997;94:8162-8167.